Capricor Therapeutics (CAPR) Operating Margin Growth (1y) (2012 - 2024)

Capricor Therapeutics (CAPR) Operating Margin Growth (1y) (2012 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,552.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -170.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Capricor Therapeutics 457.86 Mn 457.86 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -5,855.00
Sep 30, 2024 -46,427.00
Jun 30, 2024 -9,410.00
Mar 31, 2024 17,138.00
Dec 31, 2023 82,973.00
Sep 30, 2023 29,603.00
Jun 30, 2021 450,397.00
Mar 31, 2021 -1.15 Mn
Dec 31, 2020 -656,113.00
Sep 30, 2020 -2.21 Mn
Jun 30, 2020 -649,132.00
Mar 31, 2020 -2,556.00
Dec 31, 2019 -15,777.00
Sep 30, 2019 75,716.00
Jun 30, 2019 52,716.00
Mar 31, 2019 -18,799.00
Dec 31, 2018 17,934.00
Sep 30, 2018 -106,083.00
Jun 30, 2018 4,934.00
Mar 31, 2018 -51,659.00